EMAP II-Based Antiangiogenic-Antiendothelial In Vivo Combination Therapy of Pancreatic Cancer

ISSN： 1068-9265

Source： Annals of Surgical Oncology, Vol.17, Iss.5, 2010-05, pp. : 1442-1452

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination Therapy for the Treatment of Pancreatic Cancer

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 5, 2011-06 ,pp. : 418-426

Bentham Science Publishers

Access to resources Recommend Favorite

Angiogenesis and antiangiogenic strategies in pancreatic cancer

By Fisher William Berger David

International Journal of Gastrointestinal Cancer, Vol. 33, Iss. 1, 2003-02 ,pp. : 79-88

Humana Press, Inc

Access to resources Recommend Favorite

Anti-Angiogenic Agents in Pancreatic Cancer: A Review

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 5, 2011-01 ,pp. : 464-469

Bentham Science Publishers

Access to resources Recommend Favorite

Neoadjuvant Therapy in Pancreatic Cancer

By Quiros Roderick M. Brown Kimberly M. Hoffman John P.

Cancer Investigation, Vol. 25, Iss. 4, 2007-06 ,pp. : 267-273

Informa Healthcare

Access to resources Recommend Favorite

Pancreatic cancer — Adjuvant therapy

By Sultana Asma Neoptolemos John Ghaneh Paula

The Chinese-German Journal of Clinical Oncology, Vol. 6, Iss. 2, 2007-04 ,pp. : 170-175

Springer Publishing Company

Access to resources Recommend Favorite